1. Home
  2. CFLT vs KYMR Comparison

CFLT vs KYMR Comparison

Compare CFLT & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Confluent Inc.

CFLT

Confluent Inc.

HOLD

Current Price

$30.66

Market Cap

7.7B

Sector

Technology

ML Signal

HOLD

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$84.77

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFLT
KYMR
Founded
2014
2015
Country
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
6.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CFLT
KYMR
Price
$30.66
$84.77
Analyst Decision
Buy
Strong Buy
Analyst Count
29
24
Target Price
$29.13
$105.96
AVG Volume (30 Days)
18.8M
776.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$18.28
$18.36
Revenue Next Year
$16.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.64
$19.45
52 Week High
$35.76
$103.00

Technical Indicators

Market Signals
Indicator
CFLT
KYMR
Relative Strength Index (RSI) 69.01 65.24
Support Level $30.49 $76.52
Resistance Level $30.60 $86.18
Average True Range (ATR) 0.12 3.95
MACD -0.08 1.13
Stochastic Oscillator 98.72 92.10

Price Performance

Historical Comparison
CFLT
KYMR

About CFLT Confluent Inc.

Confluent Inc provides a data streaming platform that enables customers to connect their applications, systems, and data layers and can be deployed as a fully managed cloud-native software-as-a-service (SaaS) offering. Its products include Confluent Cloud, a self-managed software offering, Confluent Platform, a managed service offering where the raw data resides inside a customer's cloud environment, and WarpStream, among others. Confluent also offers professional services and education services. The company generates revenue from the sale of subscriptions and services. Geographically, it generates a majority of its revenue from its business in the United States and the rest from International markets.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: